Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Conferences of Medical Sciences Dies Natalis
Kemas Ya’kub Rahadiyanto
Clinical Pathology Department, Medical Faculty, Universitas Sriwijaya, Palembang
Biochemistry, Genetics & Molecular Biology Dentistry Health Professions Immunology & microbiology Medicine & Pharmacology Neuroscience Nursing Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
BLOOD GLUCOSE TEST FOR DM TYPE 2 Desi Oktariana; Gita Dwi Prasasty; Evi Lusiana; Nia Savitri Tamzil; Phey Liana; Kemas Ya’kub Rahadiyanto
Conferences of Medical Sciences Dies Natalis Vol. 3 No. 1 (2021): Conference of Medical Sciences Dies Natalis Faculty of Medicine Universitas Sri
Publisher : Fakultas Kedokteran Universitas Sriwijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (212.257 KB)

Abstract

Indonesia is one of the countries with a high prevalence of diabetes, with total cases of diabetes in adults reaching 10 million cases, 6.2% of the total adult population. Diabetes mellitus (DM) is a group of metabolic diseases characterized by hyperglycemia due to defects in insulin secretion, insulin action, or both. Insulin resistance in muscle and liver cells and pancreatic beta-cell failure has been recognized as the pathophysiology of major damage of type 2 diabetes. The blood glucose test is an important laboratory examination that can be used to diagnose, screen, and monitor DM type 2. There are several types of blood glucose levels, including random blood glucose tests, fasting blood glucose tests, post prandial blood glucose tests, oral Glucose Tolerance Test (OGTT), and HbA1c. Type 2 DM is often called the silent killer because sufferers are often late for self-examination and treatment so that complications arise early. Early symptoms of type 2 diabetes can be identified through blood sugar examination and risk factor screening. Screening for type 2 DM can detect abnormalities as early as possible so that interventions can start as early as possible to minimize the complication rate so that the quality of life can be maintained or better.
Co-Authors Desi Oktariana Gita Dwi Prasasty Jayawarsa, A.A. Ketut Nia Savitri Tamzil Phey Liana